Schweickert L A, Strober M, Moskowitz A
Neuropsychiatric Institute and Hospital, School of Medicine, University of California at Los Angeles 90024-1759, USA.
Int J Eat Disord. 1997 Apr;21(3):299-301. doi: 10.1002/(sici)1098-108x(199704)21:3<299::aid-eat11>3.0.co;2-w.
This case describes the beneficial effect on the binge eating component of bulimia nervosa of methylphenidate, which was prescribed to treat comorbid attention-deficit/hyperactivity disorder. Possible mechanisms of action are discussed.
本病例描述了哌甲酯对神经性贪食症暴饮暴食症状的有益作用,该药物被用于治疗共病的注意力缺陷/多动障碍。文中还讨论了可能的作用机制。